Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
All Genders
Healthy Volunteers
NCT04986332

Multidimensional Approach for COPD and High Complexity

Led by Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo · Updated on 2023-02-22

300

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The MACH Study trial will examine the impact on high complexity COPD patients of a multidimensional approach (moderate-intensity physical activity program and clinic-therapeutic re-evaluation of the participants)

CONDITIONS

Official Title

Multidimensional Approach for COPD and High Complexity

Who Can Participate

Age: 45Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide signed and dated informed consent form
  • Willing to comply with all study procedures and be available for the duration of the study
  • Diagnosed with COPD according to GOLD 2020 Guidelines or Heart Failure according to ESC 2016 Guidelines
  • Diagnosed with at least two other chronic diseases in addition to COPD or Heart Failure
  • Healthy subjects eligible only for the control group
  • Chronic diseases considered include Type 1 or Type 2 Diabetes mellitus, Essential hypertension, Chronic Kidney Disease Stage 3b or worse, Chronic Anemia of moderate level or lower, Chronic liver disease of any cause, and Obesity (BMI ≥ 30)
Not Eligible

You will not qualify if you...

  • Active cigarette smoking
  • Need for continuous supportive oxygen therapy
  • Walking less than 300 meters in 6-minute walking test
  • Unstable angina, history of cardiac arrest, severe heart failure (NYHA Class III or IV), severe left ventricular dysfunction (EF <30%), acute myocarditis, pericarditis, hypertrophic myocardiopathy, significant aortic stenosis, presence of cardiac defibrillator or heart transplant, history of large aortic aneurysm or repair
  • Uncontrolled or partially controlled asthma, sleep apnea syndrome, history of pulmonary fibrosis
  • Recent acute cardiac or cerebral event within last six months
  • Child-Pugh B/C cirrhosis
  • Body Mass Index ≥ 35
  • Evidence of arrhythmias contraindicating physical activity
  • Resting heart rate below 45 or above 100 beats per minute
  • History of uncontrolled or partially controlled high blood pressure despite treatment
  • Regular physical activity practice (only sedentary participants eligible)
  • Inability to perform 24-week physical activity program due to medical reasons
  • Acute or chronic diseases affecting systemic inflammation markers
  • Muscle conditions affecting myokine release
  • Acute bleeding or recent urgent anemia transfusion
  • Active or recent cancer treatment
  • Uncontrolled psychiatric disorders
  • Recent alcohol or substance abuse
  • Severe cognitive impairment or inability to comply
  • Other conditions deemed exclusionary by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Domenico Di Raimondo

Palermo, Italy, 90127

Actively Recruiting

Loading map...

Research Team

D

Domenico Di Raimondo

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here